ID   DYR1A_HUMAN             Reviewed;         763 AA.
AC   Q13627; O60769; Q92582; Q92810; Q9UNM5;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   15-JUL-1998, sequence version 2.
DT   05-OCT-2010, entry version 113.
DE   RecName: Full=Dual specificity tyrosine-phosphorylation-regulated kinase 1A;
DE            EC=2.7.12.1;
DE   AltName: Full=Dual specificity YAK1-related kinase;
DE   AltName: Full=HP86;
DE   AltName: Full=Protein kinase minibrain homolog;
DE            Short=MNBH;
DE            Short=hMNB;
GN   Name=DYRK1A; Synonyms=DYRK, MNB, MNBH;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM LONG), VARIANT PRO-679, AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Fetal brain;
RX   MEDLINE=97131512; PubMed=8975710; DOI=10.1006/geno.1996.0636;
RA   Song W.J., Sternberg L.R., Kasten-Sportes C., van Keuren M.L.,
RA   Chung S.H., Slack A.C., Miller D.E., Glover T.W., Chiang P.W., Lou L.,
RA   Kurnit D.W.;
RT   "Isolation of human and murine homologues of the Drosophila minibrain
RT   gene: human homologue maps to 21q22.2 in the Down syndrome 'critical
RT   region'.";
RL   Genomics 38:331-339(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM LONG), TISSUE SPECIFICITY, AND
RP   POSSIBLE INVOLVEMENT IN DOWN SYNDROME.
RX   MEDLINE=97026291; PubMed=8872470; DOI=10.1093/hmg/5.9.1305;
RA   Guimera J., Casas C., Pucharcos C., Solans A., Domenech A.,
RA   Planas A.M., Ashley J., Lovett M., Estivill X., Pritchard M.A.;
RT   "A human homologue of Drosophila minibrain (MNB) is expressed in the
RT   neuronal regions affected in Down syndrome and maps to the critical
RT   region.";
RL   Hum. Mol. Genet. 5:1305-1310(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, TISSUE SPECIFICITY,
RP   AND DEVELOPMENTAL STAGE.
RC   TISSUE=Fetal brain;
RX   MEDLINE=96332410; PubMed=8769099; DOI=10.1006/bbrc.1996.1135;
RA   Shindoh N., Kudoh J., Maeda H., Yamaki A., Minoshima S., Shimizu Y.,
RA   Shimizu N.;
RT   "Cloning of a human homolog of the Drosophila minibrain/rat Dyrk gene
RT   from 'the Down syndrome critical region' of chromosome 21.";
RL   Biochem. Biophys. Res. Commun. 225:92-99(1996).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Promyelocytic leukemia;
RX   PubMed=9037601;
RA   Ohira M., Seki N., Nagase T., Suzuki E., Nomura N., Ohara O.,
RA   Hattori M., Sakaki Y., Eki T., Murakami Y., Saito T., Ichikawa H.,
RA   Ohki M.;
RT   "Gene identification in 1.6-Mb region of the Down syndrome region on
RT   chromosome 21.";
RL   Genome Res. 7:47-58(1997).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 4), TISSUE SPECIFICITY, POSSIBLE
RP   INVOLVEMENT IN DOWN SYNDROME, VARIANTS PHE-415 AND HIS-681, AND
RP   ALTERNATIVE SPLICING.
RX   MEDLINE=99263503; PubMed=10329007; DOI=10.1006/geno.1999.5775;
RA   Guimera J., Casas C., Estivill X., Pritchard M.A.;
RT   "Human minibrain homologue (MNBH/DYRK1): characterization, alternative
RT   splicing, differential tissue expression, and overexpression in Down
RT   syndrome.";
RL   Genomics 57:407-418(1999).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 234-380.
RC   TISSUE=Fetal brain;
RX   MEDLINE=98163741; PubMed=9503011; DOI=10.1006/geno.1997.5146;
RA   Dahmane N., Ait-Ghezala G., Gosset P., Chamoun Z.,
RA   Dufresne-Zacharia M.-C., Lopes C., Rabatel N., Gassanova-Maugenre S.,
RA   Chettouh Z., Abramowski V., Fayet E., Yaspo M.-L., Korn B.,
RA   Blouin J.-L., Lehrach H., Poustka A., Antonarakis S.E., Sinet P.-M.,
RA   Creau N., Delabar J.-M.;
RT   "Transcriptional map of the 2.5-Mb CBR-ERG region of chromosome 21
RT   involved in Down syndrome.";
RL   Genomics 48:12-23(1998).
RN   [7]
RP   INTERACTION WITH RANBP9, AND ENZYME REGULATION.
RX   PubMed=14500717; DOI=10.1074/jbc.M307556200;
RA   Zou Y., Lim S., Lee K., Deng X., Friedman E.;
RT   "Serine/threonine kinase Mirk/Dyrk1B is an inhibitor of epithelial
RT   cell migration and is negatively regulated by the Met adaptor Ran-
RT   binding protein M.";
RL   J. Biol. Chem. 278:49573-49581(2003).
RN   [8]
RP   INTERACTION WITH WDR68.
RX   PubMed=14593110; DOI=10.1074/jbc.M301769200;
RA   Skurat A.V., Dietrich A.D.;
RT   "Phosphorylation of Ser640 in muscle glycogen synthase by DYRK family
RT   protein kinases.";
RL   J. Biol. Chem. 279:2490-2498(2004).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-145 AND TYR-321, AND
RP   MASS SPECTROMETRY.
RX   PubMed=15592455; DOI=10.1038/nbt1046;
RA   Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,
RA   Zha X.-M., Polakiewicz R.D., Comb M.J.;
RT   "Immunoaffinity profiling of tyrosine phosphorylation in cancer
RT   cells.";
RL   Nat. Biotechnol. 23:94-101(2005).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-145, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Lung carcinoma;
RX   PubMed=18083107; DOI=10.1016/j.cell.2007.11.025;
RA   Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,
RA   Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,
RA   Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,
RA   Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,
RA   Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.;
RT   "Global survey of phosphotyrosine signaling identifies oncogenic
RT   kinases in lung cancer.";
RL   Cell 131:1190-1203(2007).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-321, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=17192257; DOI=10.1074/mcp.T600062-MCP200;
RA   Wissing J., Jaensch L., Nimtz M., Dieterich G., Hornberger R.,
RA   Keri G., Wehland J., Daub H.;
RT   "Proteomics analysis of protein kinases by target class-selective
RT   prefractionation and tandem mass spectrometry.";
RL   Mol. Cell. Proteomics 6:537-547(2007).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-321, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Mammary epithelium;
RX   PubMed=17389395; DOI=10.1073/pnas.0608638104;
RA   Wolf-Yadlin A., Hautaniemi S., Lauffenburger D.A., White F.M.;
RT   "Multiple reaction monitoring for robust quantitative proteomic
RT   analysis of cellular signaling networks.";
RL   Proc. Natl. Acad. Sci. U.S.A. 104:5860-5865(2007).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-321, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Platelet;
RX   PubMed=18088087; DOI=10.1021/pr0704130;
RA   Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,
RA   Schuetz C., Walter U., Gambaryan S., Sickmann A.;
RT   "Phosphoproteome of resting human platelets.";
RL   J. Proteome Res. 7:526-534(2008).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-321; SER-748 AND
RP   SER-758, AND MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-321, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Embryonic kidney;
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-321, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Mammary epithelium;
RX   PubMed=19534553; DOI=10.1021/pr900044c;
RA   Heibeck T.H., Ding S.-J., Opresko L.K., Zhao R., Schepmoes A.A.,
RA   Yang F., Tolmachev A.V., Monroe M.E., Camp D.G. II, Smith R.D.,
RA   Wiley H.S., Qian W.-J.;
RT   "An extensive survey of tyrosine phosphorylation revealing new sites
RT   in human mammary epithelial cells.";
RL   J. Proteome Res. 8:3852-3861(2009).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-145; TYR-321 AND
RP   SER-324, AND MASS SPECTROMETRY.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [18]
RP   VARIANT [LARGE SCALE ANALYSIS] PRO-679.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: May play a role in a signaling pathway regulating
CC       nuclear functions of cell proliferation. Phosphorylates serine,
CC       threonine and tyrosine residues in its sequence and in exogenous
CC       substrates.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- ENZYME REGULATION: Inhibited by RANBP9.
CC   -!- SUBUNIT: Interacts RAD54L2/ARIP4 (By similarity). Interacts with
CC       RANBP9. Interacts with WDR68.
CC   -!- INTERACTION:
CC       P31946:YWHAB; NbExp=3; IntAct=EBI-1053596, EBI-359815;
CC   -!- SUBCELLULAR LOCATION: Nucleus speckle.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC         Comment=Additional isoforms seem to exist;
CC       Name=Long;
CC         IsoId=Q13627-1; Sequence=Displayed;
CC       Name=1;
CC         IsoId=Q13627-2; Sequence=VSP_004917;
CC       Name=2;
CC         IsoId=Q13627-3; Sequence=VSP_004918, VSP_004919;
CC       Name=3;
CC         IsoId=Q13627-4; Sequence=VSP_004920, VSP_004921;
CC       Name=4;
CC         IsoId=Q13627-5; Sequence=VSP_004922, VSP_004923;
CC   -!- TISSUE SPECIFICITY: Ubiquitous. Highest levels in skeletal muscle,
CC       testis, fetal lung and fetal kidney.
CC   -!- DEVELOPMENTAL STAGE: Expressed in the developing central nervous
CC       system. Overexpressed 1.5-fold in fetal Down syndrome brain.
CC   -!- PTM: Autophosphorylated on tyrosine residues.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CMGC
CC       Ser/Thr protein kinase family. MNB/DYRK subfamily.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U58496; AAC50939.1; -; mRNA.
DR   EMBL; U52373; AAB18639.1; -; mRNA.
DR   EMBL; D85759; BAA12866.1; -; mRNA.
DR   EMBL; D86550; BAA13110.1; -; mRNA.
DR   EMBL; AF108830; AAD31169.1; -; mRNA.
DR   EMBL; AJ001870; CAA05059.1; -; mRNA.
DR   IPI; IPI00014344; -.
DR   IPI; IPI00219250; -.
DR   IPI; IPI00219251; -.
DR   IPI; IPI00219252; -.
DR   IPI; IPI00941492; -.
DR   PIR; JC4898; JC4898.
DR   RefSeq; NP_001387.2; -.
DR   RefSeq; NP_567824.1; -.
DR   RefSeq; NP_569120.1; -.
DR   RefSeq; NP_569122.1; -.
DR   UniGene; Hs.368240; -.
DR   PDB; 2VX3; X-ray; 2.40 A; A/B/C/D=127-485.
DR   PDB; 2WO6; X-ray; 2.50 A; A/B=127-485.
DR   PDBsum; 2VX3; -.
DR   PDBsum; 2WO6; -.
DR   ProteinModelPortal; Q13627; -.
DR   IntAct; Q13627; 13.
DR   MINT; MINT-1205413; -.
DR   STRING; Q13627; -.
DR   PhosphoSite; Q13627; -.
DR   PRIDE; Q13627; -.
DR   Ensembl; ENST00000398960; ENSP00000381932; ENSG00000157540.
DR   GeneID; 1859; -.
DR   KEGG; hsa:1859; -.
DR   UCSC; uc002ywi.1; human.
DR   UCSC; uc002ywj.1; human.
DR   UCSC; uc002ywk.1; human.
DR   UCSC; uc002ywl.1; human.
DR   CTD; 1859; -.
DR   GeneCards; GC21P038739; -.
DR   HGNC; HGNC:3091; DYRK1A.
DR   HPA; HPA015323; -.
DR   HPA; HPA015810; -.
DR   MIM; 600855; gene.
DR   PharmGKB; PA27545; -.
DR   eggNOG; prNOG04928; -.
DR   HOGENOM; HBG755340; -.
DR   HOVERGEN; HBG051425; -.
DR   InParanoid; Q13627; -.
DR   OMA; HRHSGGH; -.
DR   BRENDA; 2.7.12.1; 247.
DR   NextBio; 7615; -.
DR   ArrayExpress; Q13627; -.
DR   Bgee; Q13627; -.
DR   CleanEx; HS_DYRK1A; -.
DR   Genevestigator; Q13627; -.
DR   GermOnline; ENSG00000157540; Homo sapiens.
DR   GO; GO:0016607; C:nuclear speck; ISS:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004715; F:non-membrane spanning protein tyrosine kina...; IDA:MGI.
DR   GO; GO:0043621; F:protein self-association; ISS:UniProtKB.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; ISS:UniProtKB.
DR   GO; GO:0007399; P:nervous system development; TAS:ProtInc.
DR   GO; GO:0018108; P:peptidyl-tyrosine phosphorylation; ISS:UniProtKB.
DR   GO; GO:0046777; P:protein amino acid autophosphorylation; ISS:UniProtKB.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR017442; Se/Thr_prot_kinase-like_dom.
DR   InterPro; IPR008271; Ser/Thr_prot_kinase_AS.
DR   InterPro; IPR002290; Ser/Thr_prot_kinase_dom.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Complete proteome;
KW   Kinase; Nucleotide-binding; Nucleus; Phosphoprotein; Polymorphism;
KW   Serine/threonine-protein kinase; Transferase; Tyrosine-protein kinase.
FT   CHAIN         1    763       Dual specificity tyrosine-
FT                                phosphorylation-regulated kinase 1A.
FT                                /FTId=PRO_0000085931.
FT   DOMAIN      159    479       Protein kinase.
FT   NP_BIND     165    173       ATP (By similarity).
FT   MOTIF       117    134       Bipartite nuclear localization signal
FT                                (Potential).
FT   COMPBIAS    509    515       Poly-Ser.
FT   COMPBIAS    599    602       Poly-His.
FT   COMPBIAS    607    619       Poly-His.
FT   COMPBIAS    656    672       Ser/Thr-rich.
FT   COMPBIAS    664    671       Poly-Ser.
FT   ACT_SITE    287    287       Proton acceptor (By similarity).
FT   BINDING     188    188       ATP (By similarity).
FT   MOD_RES     145    145       Phosphotyrosine.
FT   MOD_RES     219    219       Phosphotyrosine; by autocatalysis (By
FT                                similarity).
FT   MOD_RES     319    319       Phosphotyrosine; by autocatalysis (By
FT                                similarity).
FT   MOD_RES     321    321       Phosphotyrosine; by autocatalysis.
FT   MOD_RES     324    324       Phosphoserine.
FT   MOD_RES     748    748       Phosphoserine.
FT   MOD_RES     758    758       Phosphoserine.
FT   VAR_SEQ      70     78       Missing (in isoform 1).
FT                                /FTId=VSP_004917.
FT   VAR_SEQ     516    540       GGSSGTSNSGRARSDPTHQHRHSGG -> VEQHWMPGAFRM
FT                                TVSFTLEVHDVPV (in isoform 3).
FT                                /FTId=VSP_004920.
FT   VAR_SEQ     516    529       GGSSGTSNSGRARS -> GASAISCSSWLVRH (in
FT                                isoform 2).
FT                                /FTId=VSP_004918.
FT   VAR_SEQ     530    763       Missing (in isoform 2).
FT                                /FTId=VSP_004919.
FT   VAR_SEQ     541    763       Missing (in isoform 3).
FT                                /FTId=VSP_004921.
FT   VAR_SEQ     559    584       RQQFPAPLGWSGTEAPTQVTVETHPV -> SSHVVHLLVSP
FT                                AILRWSSTGCQVPLE (in isoform 4).
FT                                /FTId=VSP_004922.
FT   VAR_SEQ     585    763       Missing (in isoform 4).
FT                                /FTId=VSP_004923.
FT   VARIANT     415    415       Y -> F.
FT                                /FTId=VAR_009395.
FT   VARIANT     679    679       A -> P (in dbSNP:rs55720916).
FT                                /FTId=VAR_040453.
FT   VARIANT     681    681       Q -> H.
FT                                /FTId=VAR_009396.
FT   CONFLICT     32     32       G -> A (in Ref. 1; AAC50939).
FT   CONFLICT     47     47       N -> S (in Ref. 1; AAC50939).
FT   CONFLICT     57     57       S -> P (in Ref. 1; AAC50939).
FT   CONFLICT    123    123       Q -> R (in Ref. 1; AAC50939).
FT   CONFLICT    266    266       A -> V (in Ref. 6; CAA05059).
FT   CONFLICT    357    357       G -> R (in Ref. 6; CAA05059).
FT   CONFLICT    397    397       K -> N (in Ref. 1; AAC50939).
FT   CONFLICT    592    592       A -> G (in Ref. 1; AAC50939).
FT   TURN        156    158
FT   STRAND      159    164
FT   STRAND      173    178
FT   TURN        179    182
FT   STRAND      183    189
FT   HELIX       194    212
FT   HELIX       216    220
FT   STRAND      224    230
FT   STRAND      233    239
FT   HELIX       245    251
FT   TURN        252    254
FT   HELIX       259    276
FT   TURN        279    281
FT   HELIX       290    292
FT   STRAND      293    297
FT   STRAND      303    305
FT   HELIX       325    327
FT   HELIX       330    333
FT   HELIX       341    346
FT   HELIX       350    355
FT   HELIX       366    376
FT   HELIX       382    385
FT   HELIX       391    394
FT   STRAND      395    397
FT   STRAND      403    405
FT   HELIX       423    426
FT   HELIX       446    459
FT   TURN        464    466
FT   HELIX       470    473
FT   HELIX       477    479
SQ   SEQUENCE   763 AA;  85584 MW;  7C3A52A3CBB04FB5 CRC64;
     MHTGGETSAC KPSSVRLAPS FSFHAAGLQM AGQMPHSHQY SDRRQPNISD QQVSALSYSD
     QIQQPLTNQV MPDIVMLQRR MPQTFRDPAT APLRKLSVDL IKTYKHINEV YYAKKKRRHQ
     QGQGDDSSHK KERKVYNDGY DDDNYDYIVK NGEKWMDRYE IDSLIGKGSF GQVVKAYDRV
     EQEWVAIKII KNKKAFLNQA QIEVRLLELM NKHDTEMKYY IVHLKRHFMF RNHLCLVFEM
     LSYNLYDLLR NTNFRGVSLN LTRKFAQQMC TALLFLATPE LSIIHCDLKP ENILLCNPKR
     SAIKIVDFGS SCQLGQRIYQ YIQSRFYRSP EVLLGMPYDL AIDMWSLGCI LVEMHTGEPL
     FSGANEVDQM NKIVEVLGIP PAHILDQAPK ARKFFEKLPD GTWNLKKTKD GKREYKPPGT
     RKLHNILGVE TGGPGGRRAG ESGHTVADYL KFKDLILRML DYDPKTRIQP YYALQHSFFK
     KTADEGTNTS NSVSTSPAME QSQSSGTTSS TSSSSGGSSG TSNSGRARSD PTHQHRHSGG
     HFTAAVQAMD CETHSPQVRQ QFPAPLGWSG TEAPTQVTVE THPVQETTFH VAPQQNALHH
     HHGNSSHHHH HHHHHHHHHG QQALGNRTRP RVYNSPTNSS STQDSMEVGH SHHSMTSLSS
     STTSSSTSSS STGNQGNQAY QNRPVAANTL DFGQNGAMDV NLTVYSNPRQ ETGIAGHPTY
     QFSANTGPAH YMTEGHLTMR QGADREESPM TGVCVQQSPV ASS
//
